Table 1.
Demographic and clinical characteristics of the subjects in this round of follow-up.
| Characteristics | All patients | Unvaccinated | Vaccinated | Pa |
|---|---|---|---|---|
| Total | 318 | 274 | 44 | |
| Gender | 0.222 | |||
| Male | 150(47.2) | 133(48.54) | 17(38.64) | |
| Female | 168(52.8) | 141(51.46) | 27(61.36) | |
| Age (mean,95%CI) | 45.21 (43.44,46.98) | 45.46 (43.49,47.42) | 43.70 (40.00,47.40) | 0.503 |
| Age (ys) | 0.201 | |||
| <20 | 17(5.35) | 17(6.20) | 0(0.00) | |
| 20~ | 32(10.06) | 28(10.22) | 4(9.09) | |
| 30~ | 79(24.84) | 64(23.36) | 15(34.09) | |
| 40~ | 54(16.98) | 44(16.06) | 10(22.73) | |
| 50~ | 74(23.27) | 64(23.36) | 10(22.73) | |
| ≥60 | 62(19.50) | 57(20.80) | 5(11.36) | |
| Severity of disease | 0.100 | |||
| Asymptomatic type | 92(28.93) | 82(29.93) | 10(22.73) | |
| Mild type | 60(18.87) | 46(16.79) | 14(31.82) | |
| Normal type | 162(50.94) | 143(52.19) | 19(43.18) | |
| Severe/Critical type | 4(1.26) | 3(1.09) | 1(2.27) | |
| SARS-CoV-2 vaccination | ||||
| Unvaccinated | 274(86.16) | |||
| Vaccinated | 44(13.84) |
aChi-square test or fisher’s exact test as appropriate;
P < 0.05 represents significant difference.